American Portfolios Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

American Portfolios Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.27K	Hold	45	–	–	﹤0.01%	3231
2022 Q2	$998	Hold	45	–	–	﹤0.01%	3276
2022 Q1	$1.31K	Hold	45	–	–	﹤0.01%	3313
2021 Q4	$1.48K	Hold	45	–	–	﹤0.01%	3247
2021 Q3	$2.08K	Hold	45	–	–	﹤0.01%	3152
2021 Q2	$2.48K	Hold	45	–	–	﹤0.01%	3087
2021 Q1	$2.32K	Hold	45	–	–	﹤0.01%	2957
2020 Q4	$1.95K	Hold	45	–	–	﹤0.01%	2708
2020 Q3	$1.57K	Hold	45	–	–	﹤0.01%	2673
2020 Q2	$2.41K	Hold	45	–	–	﹤0.01%	2487
2020 Q1	$1.6K	Sell	45 -1,720	-97%	-$79.5K	﹤0.01%	2464
2019 Q4	$84.3K	Buy	1,765 +1,720	+3,822%	+$65K	0.01%	1136
2019 Q3	$1.46K	Hold	45	–	–	﹤0.01%	2583
2019 Q2	$2.25K	Hold	45	–	–	﹤0.01%	2445
2019 Q1	$3.04K	Hold	45	–	–	﹤0.01%	2251
2018 Q4	$2.08K	Hold	45	–	–	﹤0.01%	2132
2018 Q3	$3.47K	Hold	45	–	–	﹤0.01%	2111
2018 Q2	$3.79K	Hold	45	–	–	﹤0.01%	2072
2018 Q1	$3.68K	Hold	45	–	–	﹤0.01%	1977
2017 Q4	$2.57K	Buy	+45	New	+$2.83K	﹤0.01%	2000

Other funds holding AGIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American Portfolios Advisors's AGIO Position: Q3 2022 in Review

American Portfolios Advisors held its Agios Pharmaceuticals (AGIO) position steady in Q3 2022 at 45 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #3231.

American Portfolios Advisors first reported a position in AGIO in Q4 2017 and has held it in 20 quarters since. The position peaked at $84.3K in Q4 2019. 168 funds tracked by Wall St. Rank hold AGIO as of Q3 2022.

American Portfolios Advisors held 45 shares of Agios Pharmaceuticals worth $1.27K as of Q3 2022.
American Portfolios Advisors left its Agios Pharmaceuticals share count unchanged in Q3 2022.
Agios Pharmaceuticals made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3231 holding.
American Portfolios Advisors first reported a position in Agios Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
American Portfolios Advisors's Agios Pharmaceuticals position peaked at $84.3K in Q4 2019.
168 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.